Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pneumonia IV: Management01:28

Pneumonia IV: Management

312
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
312
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Tonsillitis II: Management01:26

Tonsillitis II: Management

105
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
105
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

78
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
78
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

111
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric inpatient influenza vaccination before, during and after the COVID-19 pandemic.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative.

PloS one·2026
Same author

Fontan-associated liver disease: The role of liver elastography assessments pre- and post-heart transplant.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Results of a local modified Delphi consensus on use of plasma metagenomic next-generation sequencing.

Infection control and hospital epidemiology·2025
Same author

Direct cost savings associated with reduction in plasma metagenomic sequencing.

Infection control and hospital epidemiology·2025

Related Experiment Video

Updated: Jun 15, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format.

Naseem Ravanbakhsh1, Andres Rivera Campana1, Catherine Chapin1,2

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Journal of the Pediatric Infectious Diseases Society
|August 22, 2024
PubMed
Summary

Pediatric hepatitis B virus (HBV) management is challenging due to potential long-term liver damage and unclear treatment guidelines. This review addresses common clinical scenarios to guide evaluation and treatment of HBV infection in children.

Keywords:
childrenhepatitis B viruspreventiontreatmentvaccine

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.2K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.2K

Related Experiment Videos

Last Updated: Jun 15, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.2K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.2K

Area of Science:

  • Pediatric Hepatology
  • Viral Hepatitis Management
  • Clinical Pediatrics

Background:

  • Hepatitis B virus (HBV) infection in children poses significant risks, including hepatic fibrosis, cirrhosis, and malignancy.
  • Current pediatric HBV management lacks definitive guidelines for treatment initiation timing.
  • Effective management is crucial to prevent severe long-term sequelae.

Purpose of the Study:

  • To review common clinical scenarios in the evaluation and treatment of pediatric HBV infection.
  • To provide evidence-based guidance for managing HBV in children.
  • To discuss landmark studies and evolving practices in pediatric HBV care.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Presentation of common pediatric HBV clinical vignettes.
  • Discussion of evidence-based practices and landmark studies.

Main Results:

  • Identified key challenges in pediatric HBV management.
  • Highlighted the need for clear treatment initiation protocols.
  • Emphasized the importance of timely and appropriate intervention.

Conclusions:

  • Clinical scenarios can effectively illustrate best practices for pediatric HBV management.
  • A comprehensive approach integrating guidelines, evidence, and evolving research is essential.
  • Improved understanding and application of management strategies can mitigate long-term risks in children with HBV.